A 9-year-old Korean girl with Fontaine progeroid syndrome: a case report with further phenotypical delineation and description of clinical course during long-term follow-up by Ryu, Jaehui et al.
CASE REPORT Open Access
A 9-year-old Korean girl with Fontaine
progeroid syndrome: a case report with
further phenotypical delineation and
description of clinical course during long-
term follow-up
Jaehui Ryu, Jung Min Ko* and Choong-Ho Shin
Abstract
Background: Gorlin–Chaudhry–Moss syndrome (GCMS) and Fontaine–Farriaux syndrome (FFS) are extremely rare
genetic disorders that share similar clinical manifestations. Because a de novo missense mutation of the solute
carrier family 25 member 24 (SLC25A24) gene was suggested to be the common genetic basis of both syndromes,
it has been proposed recently that they be integrated into a single disorder under the name of Fontaine progeroid
syndrome (FPS).
Case presentation: A 9-year-old Korean girl presented with typical clinical features of FPS. She had generalized
loose skin with decreased subcutaneous fat, skin wrinkling on the forehead and limbs, skull deformities and a
peculiar facial appearance with microphthalmia and midface hypoplasia, anomalies of the digits and nails, a large
umbilical hernia and a nearly normal developmental outcome. She exhibited prenatal and postnatal growth
retardation together with short stature, and records showed that her height and weight were invariably under − 2.0
SD from birth to the age of 10 years. SLC25A24 analysis revealed a heterozygous mutation reported previously, NM_
013386:c.650G > A, p.[Arg217His]. After screening her family for the identified mutation, she was confirmed as being
a de novo case of FPS caused by an SLC25A24 mutation.
Conclusion: We describe a Korean girl with typical clinical findings of FPS and a de novo mutation in SLC25A24, as
well as 10 years of clinical follow-up, including growth and developmental achievements.
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Background
Gorlin–Chaudhry–Moss syndrome (GCMS) was first
described in 1960 in two girls who had clinical manifesta-
tions of craniosynostosis, midface hypoplasia, oligodontia,
hypertrichosis, patent ductus arteriosus, anomalies of the
eyes and hypoplasia of the labia majora [1]. Since then,
additional cases with a similar phenotypic spectrum have
been reported [2–4] and it has been suggested that GCMS
might be inherited in an autosomal recessive or X-linked
dominant pattern with male lethality because all reported
subjects were females. Fontaine–Farriaux syndrome (FFS)
was independently reported in 1977 in a patient with bra-
chycephaly, anonychia, abdominal muscle hypoplasia and
central nervous system anomalies who died at the age of
3 years [5]. Several additional cases of FFS were reported,
but all of these patients died before 7months of age. Even
though FFS shares features with GCMS, it was considered
to be a separate entity because patients with FFS included
both males and females and all died at a younger age than
those with GCMS [6–8].
However, with the introduction of next-generation se-
quencing technologies, including trio exome sequencing
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and whole-genome sequencing, de novo missense muta-
tions in the hot spot of SLC25A24 were suggested as the
molecular aetiology of both GCMS and FFS by two in-
dependent groups in 2017 [9, 10]. Thus, the inheritance
pattern of GCMS and FFS could be considered as being
autosomal dominant. Because GCMS and FFS share
similar clinical presentations and genetic aetiology,
Writzl et al. first suggested integrating the two syn-
dromes under the name of Fontaine progeroid syndrome
(FPS) because of their patients, who were originally diag-
nosed as having FFS [10]. The syndromes are now con-
sidered as the same disorder on OMIM, under FPS [11],
with a wide spectrum of clinical manifestations and se-
verity. However, FPS is extremely rare, with an estimated
prevalence of less than 1 in 1,000,000, and only 10 cases
(three males and seven females) reported to date [12].
We report a Korean girl with a de novo mutation,
NM_013386:c.650G > A, p.[Arg217His], in SLC25A24
and typical clinical findings of FPS. We also summarize
the clinical course of her disease over 10 years.
Case presentation
The patient was born at 31 weeks and 6 days of gesta-
tional age to unrelated healthy parents. No abnormality
was found on prenatal sonographic screening and the
pregnancy was uneventful until oligohydramnios was
observed at 26 weeks, which led to delivery at a birth
weight of 1.08 kg (− 1.8 SD) by emergency caesarean
section. She was transferred to the neonatal intensive
care unit after birth and remained in care for 3 months.
Physical examination showed that she had generalized
loose skin, hypertrichosis and an umbilical hernia. She had
a dysmorphic face with epicanthus inversus, depressed
nasal bridge and low hairline. A congenital skull defect with
anterior fontanelle widening and a softened occipital and
parietal calvarium were observed. In addition, she had hy-
poplastic nails and syndactyly of the left 4th and 5th fingers.
Based on her clinical phenotype, cutis laxa was initially sus-
pected and conventional karyotyping and direct sequencing
of ATP6V0A2 were performed. However, the results of
these analyses were normal.
At the age of 4 months, she visited our hospital for the
evaluation of multiple congenital malformations, includ-
ing congenital skull deformity and hypoplasia of fingers
and nails. At that time, her head circumference was 34.3 cm
(− 3.8 SD) and radiologic and sonographic findings showed
interparietal widening and mild dilatation of the lateral ven-
tricles. Simple radiographs of both hands revealed the ab-
sence of the distal phalanx in the 5th fingers and hypoplastic
distal phalanges of both sets of 2nd to 4th fingers. Pure tone
audiometry revealed mild conductive hearing loss. However,
magnetic resonance imaging of the brain and orbit did not
find any abnormalities, including the previously noted mild
lateral ventricular dilatation. Abdominal sonography and
echocardiography showed no structural anomalies, with the
exception of a large umbilical hernia.
At the age of 4 years, she underwent a series of surgi-
cal procedures, including division of syndactyly of the
left 4th and 5th fingers, entropion repair of both upper
eyelids and repair of the umbilical hernia. She needed
regular ophthalmologic follow-up because of esotropia
and severe hyperopia. Her early psychomotor develop-
ment was delayed as she sat unsupported at 18 months,
spoke several words at 24 months and walked independ-
ently when she was 36months old. However, catch-up
development allowed her to reach the level of her peers
and she is now doing well in school.
At the age of 8 years, she visited the paediatric genetics
clinic of our institution for the identification of the
underlying genetic aetiology of her dysmorphic features.
Her height, weight and head circumference were 115.0
cm (− 3.0 SD), 15.0 kg (− 4.9 SD) and 48.5 cm (− 2.0 SD),
respectively. She had progeroid features with loose skin
and wrinkling on the forehead and limbs, as well as gen-
eralized hypertrichosis, especially on the forehead and
back. A dysmorphic facial appearance with microphthal-
mia, epicanthus inversus, midface hypoplasia, narrow
forehead and low hair line (Fig. 1a), and dysplastic ears
with a small and wrinkled morphology were noted. She
also had hypoplastic nails on both 5th fingers and left
4th finger (Fig. 1b). The umbilical hernia (Fig. 1c) re-
curred despite a previous repair operation. Orodental
examination revealed a bifid uvula and oligodontia with
malocclusion. Although her growth velocity was within
the normal range, her height and weight profiles
remained under − 2.0 SD (Fig. 1d). A growth hormone
(GH) stimulation test and a low-dose adrenocortico-
tropin stimulation test were performed to rule out
pituitary and hypothalamic dysfunction; the results of
both tests were normal. At the age of 9 years, a dilated
ascending aorta (2.7 cm, + 5.0 SD) was detected using
chest computed tomography during pre-operative
evaluation of esotropia repair.
Based on the medical history and physical examina-
tions, the girl was suspected of having FPS. A chromo-
somal microarray analysis and direct sequencing of the
mutation hot spot of SLC25A24 for FPS were performed.
Written informed consent was obtained from the patient
and her parents, and the Institutional Review Board of
the Seoul National University Hospital approved this
study. The chromosomal microarray analysis did not
identify any pathologic copy number variations (Add-
itional file 1), while analysis of exon 5 of SLC25A24
revealed a heterozygous mutation reported previously,
NM_013386:c.650G > A, p.[Arg217His] (Fig. 2). Because
her parents and two brothers did not carry this muta-
tion, our patient was confirmed as being a de novo case
of FPS caused by an SLC25A24 mutation.
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Discussion and conclusion
The SLC25A24 gene encodes a mitochondrial inner-
membrane transporter, ATP-Mg/Pi carrier, which
consists of six helical structures. Among the SLC25A24
protein structures, Arg217 plays an important role in
maintaining four strong hydrogen bonds between helices
2 and 3 [14]. Patients with FPS reported previously had
a concurrent mutation on Arg217, either p.[Arg217His]
or p.[Arg217Cys] [9–11]. This leads to distortion of the
structure of the ATP-Mg/Pi carrier by narrowing the
substrate cavity and disturbing the entry of nucleosides
into the carrier. If nucleoside entry is disturbed and an
adequate adenine level is not achieved in the
mitochondrial matrix, mitochondria undergo calcium
overload, which triggers mitochondrial permeability
transition mediated by mitochondrial permeability tran-
sition pores; this leads to disruption of the mitochondrial
membrane potential, mitochondrial swelling and, finally,
to cell death [14]. Accordingly, cells with mutated
SLC25A24 are more susceptible to death; this mechan-
ism contributes to several clinical features, such as lipoa-
trophy or skeletal underdevelopment, which can cause a
progeroid appearance. However, because this mechan-
ism cannot explain phenotypes such as microphthalmia
or hypertrichosis, the actual mechanism underlying this
condition must be determined.
Fig. 1 Clinical features of the case reported here. a: The characteristic facial appearance included hypertrichosis, frontal bossing, and a low
hairline. b: Hypoplastic distal phalanges and anonychia are noted in the left 4th and both 5th fingers. c: The patient underwent repair of a large
umbilical hernia. d: The height and weight up to 10 years of age are plotted against a Korean national growth chart [13]. The square markers
indicate the data pertaining to our patient
Fig. 2 Sanger-sequencing chromatogram of our patient. Partial sequencing of the cloning allele of SLC25A24 showed the presence of a
heterozygous missense mutation, NM_013386:c.650G > A, p.[Arg217His], in exon 5
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After SLC25A24 was reported as the common genetic
basis of GCMS and FFS, both syndromes were in-
tegrated into a single disorder under the name of FPS
[9–11]. The major clinical presentations of FPS, as docu-
mented in Table 1, include a generally aged appearance
with loose or wrinkled skin, short stature, hypertrichosis,
skull deformities with craniosynostosis or brachycephaly
and a characteristic facial appearance of depressed nasal
bridge, low hairline and microphthalmia. These patients
also exhibit digit and nail anomalies, cardiovascular ab-
normalities, umbilical hernia, a hypoplastic genital sys-
tem and normal or nearly normal developmental
outcomes. However, FPS was known as two separate
entities, GCMS and FFS, because of major differences
between them, i.e. patients with GCMS were mostly
female and most patients with FFS died before 1 year of
age. To date, a total of 11 patients, three males and eight
females, were genetically confirmed as having FPS. Two
out of the three male patients died before 12 months of
Table 2 Demographic information of all reported cases of FPS-related syndromes








Gorlin et al. (1960) [1] F 10 years
F 8 years
Ippel et al. (1992) [2] F 4 years
F 33 years
Aravena et al. (2011) [3] F 5 months pneumonia
F 18months pneumonia
Rosti et al. (2013) [4] F 4 years
Ehmke et al. (2017) [9] F 5.5 years +
F 7 years +
F 5 years +
F 20months urinary tract
infection
+
F 14 years +
Our patient (2018) F 9 years +
Fontaine-Farriaux syndrome (FFS) Fontaine et al. (1977) [5] M 3months unknown
Faivre et al. (1999) [6] F 7 months sepsis +
Rodriguez et al. (1999) [7] F 7 h respiratory distress +
Castori et al. (2009) [8] M 20 h respiratory distress +





M 15 years +
Petty-Laxova-Wiedemann syndrome
(PLWS)
Petty et al. (1990) [15] F 45 years
F 5 years
Delgado et al. (2009)
[16]
M 10 years
Braddock et al. (2010)
[17]
F 7 months respiratory failure
M 23months sepsis
Table 3 Heights, weights and their standard deviations
according to ages
Age Height (SD) Weight (SD)
At birth Unknown 1.1 kg (−3.8)
1 year 5 months 65.4 cm (−4.4) 4.4 kg (−10.7)
4 years 87.1 cm (−3.3) 8.5 kg (−6.9)
4 years 9 months 93.0 cm (− 3.1) 9.0 kg (−7.6)
7 years 108.3 cm (−2.7) 12.6 kg (−5.6)
8 years 9 months 115.0 cm (− 3.0) 15.0 kg (− 4.9)
9 years 7 months 120.4 cm (− 2.6) 16.4 kg (− 4.6)
9 years 11 months 121.8 cm (− 2.5) 16.9 kg (− 4.6)
10 years 2 months 123.0 cm (− 2.5) 17.5 kg (− 4.5)
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age, and there is only one case of a surviving male. In con-
trast, only one patient died before 12months of age and
two patients who died at 18 and 20months of age, among
the eight female patients. Our patient presented with
typical clinical manifestations of FPS and is more appro-
priately sub-classified as GCMS, rather than FFS, based on
conventional criteria, because she is female and has sur-
vived at least until the age of 10 years (Table 2). Further
studies are necessary to clarify the basis of the higher
prevalence of the SLC25A24 mutation in females and the
higher mortality rate in young males with FPS.
Another progeroid syndrome, Petty–Laxova–Wiede-
mann syndrome (PLWS), also presents with the typical
characteristics of FPS, including prenatal growth restric-
tion and subsequent short stature, decreased subcutane-
ous fat, coronal synostosis, umbilical hernia at birth, short
digital phalanges and normal development [15–17]. How-
ever, genetic confirmation has not been performed in any
of the reported patients with PLWS. If PLWS survivors
are available, we suggest verifying whether they harbour
the same mutation in SLC25A24. In this study, we follow
up the height and weight of our patient from infancy to
10 years of age and plotted them on a growth chart (Fig.
1d, Table 3). Considering that she was born pre-term and
was small for gestational age newborn, the height and
body weight were invariably under − 2.0 SD compared
with corrected age- and sex-matched controls. Her height
velocity was within the normal range and hormonal
evaluations did not show any deficiencies.
Because the majority of patients with FPS are expected
to have a nearly normal lifespan, the improvement of
their quality of life by correcting deformities and ma-
naging medical issues is important. One report described
the surgical correction of craniofacial malformations in a
7-year-old patient with GCMS using internal distraction
devices [18]. Another report described a 33-year-old
GCMS patient who presented with an irregular men-
strual cycle and infertility [2]. It is important to monitor
secondary sexual development and reproductive ability
in, and provide genetic counselling to, these patients.
Furthermore, because congenital cardiac anomalies are
often observed in patients with FPS [13], regular medical
surveillance of cardiovascular complications is essential.
This report presented a Korean case of FPS with genetic
confirmation, as well as long-term growth follow up. We
monitored serially the growth profile of our patient and
found that her short stature was not caused by GH
deficiency. We also organized chronologically the demo-
graphic information of related syndromes, including
GCMS, FFS and PLWS. Even though FPS is an extremely
rare disorder, efforts aimed at providing medical support
based on its pathophysiology, as well as investigating un-
resolved questions, including the mechanism underlying
the intersexual differences observed, should continue.
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